MedTrace Logo

Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma

NCT01333800 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2011-04-12

No results posted yet for this study

Summary

The Objective was to Develop a Cost-Effectiveness study that compares Ciclesonide and Beclomethasone in pediatric asthma control.

Conditions

Interventions

DRUG

Beclomethasone

200 to 400 mcg per day for 6 months

DRUG

Ciclesonide

80 to 160 mcg per day for 6 months

Sponsors & Collaborators

  • Grünenthal Colombiana S.A.

    lead INDUSTRY

Principal Investigators

  • Francisco Hinestrosa, MD,MSc · Grünenthal Colombiana S.A.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01333800 on ClinicalTrials.gov